Search PubMedSearch

Biomedical subjects

R L Fleming

Publications and source records attributed to R L Fleming.

4 recordsLinked to original sources

Dual 24-hour feeding response to 2DG in rats: daytime increase and nighttime decrease.

Thirty-six rats were injected IP with 2DG (0, 250, or 500 mg/kg) at 7-day intervals, once at light onset (7 a.m.) and once at dark onset (7 p.m.), and postinjection food intake was monitored for 24 hours. Five hundred mg/kg 2DG caused food intake to rise above control levels during the first 6 hours of daylight, regardless of whether the injection had occurred that morning or the previous evening, whereas intake during the first 6 hours of darkness was consistently below control levels. In a second study, 24 rats were injected first at 7 a.m. (500 mg/kg 2DG or saline), and 7 days later at 7 p.m. (opposite drug), and food was withheld 12 hours until the light:dark period had changed. For 12 hours after food was returned, 2DG again decreased nighttime food intake (Injection 1) and increased daytime intake (Injection 2). 2DG's dual long-term effects cannot be accounted for either by malaise or by an initial action that later is compensated by its opposite. Rather, 2DG (500 mg/kg) appears to exert two independent, opposite alimentary effects which persist 18-24 hours and which change direction with phase changes in the light:dark cycle.

Animals

A comparison between chlordiazepoxide and CL 218,872--a synthetic nonbenzodiazepine ligand for benzodiazepine receptors on spontaneous locomotor activity in rats.

Spontaneous locomotor activity was investigated in rats treated with chlordiazepoxide (CDP) or CL 218,872, a synthetic nonbenzodiazepine ligand for benzodiazepine receptors. Acute administration of CDP (2.5 mg/kg) increased activity, whereas a higher dose (10 mg/kg) decreased activity. Acute injection of CL 218,872 (2.5-10 mg/kg) produced a significant dose-dependent suppression of locomotor activity, a finding at variance with a previous report that anxiolytic doses of CL 218,872 are devoid of depressant side effects. Chronic pretreatment with CDP or CL 218,872 (10 mg/kg daily for 6 days) produced a tolerance to the sedative effect of CDP (10 mg/kg), but not to the activity suppressant action of CL 218,872 (10 mg/kg).

Animals

Demonstration of Isospora belli by acid-fast stain in a patient with acquired immune deficiency syndrome.

Isospora belli, like Cryptosporidium sp., a sporozoan parasite of the small intestine, has been isolated from both immunodeficient and immunologically normal persons. In immunocompetent persons the infection may be asymptomatic; it frequently causes mild and self-limited diarrhea. The spectrum of the disease in persons with acquired immune deficiency syndrome is not well established. I. belli did not stain well with the methods usually used for intestinal protozoa and was difficult to see unstained. However, it stained well with the acid-fast technique used for Cryptosporidium sp. and was easily identified by such stains. A case of combined infection with Cryptosporidium sp. and I. belli is reported.

Acquired Immunodeficiency Syndrome

Solid-phase colorimetric determination of potassium.

A nonpolar organic film (plasticized polyvinyl chloride) containing the ionophore valinomycin was incubated with an aqueous solution containing potassium ion and a detectable anion (erythrosin B). The amount of erythrosin B retained by the film after washing could be measured by absorbance or reflectance, and was directly related to the potassium concentration. This dye-binding method is quantitative for potassium and is suitable for both aqueous and serum-based solutions. There was no interference by sodium in the range found in serum. Several polyvinyl chloride plasticizers and anionic dyes and some other ionophores were found to be useful. The anion binding is thought to be restricted to the surface.

Colorimetry